Kearns-Sayre Syndrome Supportive Care Protocol
Primary Stack
Core supplements with strongest evidenceEssential electron carrier in respiratory chain; supports mitochondrial function; most studied supplement for KSS
Supporting Studies (1)
Supports fatty acid transport into mitochondria; often deficient in mitochondrial disease
Supporting Studies (1)
Supporting Stack
Additional supplements for enhanced resultsMultiple B vitamins are mitochondrial cofactors; supports energy production
Supporting Studies (1)
Antioxidant; mitochondrial cofactor; may help reduce oxidative stress
Supporting Studies (1)
Alternative energy substrate; may help buffer ATP deficiency
Supporting Studies (1)
Antioxidant; helps protect mitochondrial membranes from oxidative damage
Supporting Studies (1)
May help with CNS folate deficiency sometimes seen in KSS
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Kearns-Sayre Syndrome (KSS) is a rare mitochondrial disease caused by large deletions in mitochondrial DNA. It typically begins before age 20 and is characterized by a triad of features: progressive external ophthalmoplegia (difficulty moving eyes), pigmentary retinopathy, and heart conduction abnormalities.
CLASSIC TRIAD:
1. Progressive External Ophthalmoplegia (PEO) - weakness of eye muscles causing drooping eyelids and limited eye movement
2. Pigmentary Retinopathy - abnormal pigment deposits in retina
3. Heart Block - often requires pacemaker
OTHER FEATURES:
CRITICAL: KSS is a serious, progressive condition requiring multidisciplinary specialist care. This protocol is SUPPORTIVE ONLY.
MANAGEMENT PRIORITIES:
DRUGS TO AVOID:
* CoQ10 is the cornerstone of the "mitochondrial cocktail."
* L-Carnitine helps with fatty acid metabolism and is often deficient.
* B vitamins, alpha-lipoic acid, and creatine provide additional mitochondrial support.
Expected timeline: KSS is progressive. Treatment focuses on managing complications and supporting mitochondrial function. Regular monitoring for cardiac and other complications is essential.
Clinical Perspective
Kearns-Sayre Syndrome: Mitochondrial DNA deletion syndrome. Diagnosis: onset <20 years + PEO + pigmentary retinopathy + at least one of: cardiac conduction block, CSF protein >100mg/dL, cerebellar ataxia. Large single mtDNA deletions (usually sporadic, not inherited). Progressive; multisystem involvement.
CRITICAL: Cardiac conduction defects can be fatal - regular ECG monitoring; low threshold for pacemaker (prophylactic recommended by some). No cure - supportive care. "Mitochondrial cocktail" empirically used. Avoid mitochondrial toxins (valproic acid, aminoglycosides, certain anesthetics). Monitor for diabetes, hypoparathyroidism, hearing loss, swallowing problems. Prognosis: variable but often progressive; cardiac involvement main determinant of survival.
* CoQ10 (B-grade): Electron carrier. Systematic review: (PMID: 24268541). 100-600mg daily. Cornerstone of mito cocktail.
* L-Carnitine (B-grade): Fatty acid transport. Review: (PMID: 23597877). 30-100mg/kg/day. Secondary deficiency common.
* B-Complex (C-grade): Mitochondrial cofactors. Review: (PMID: 27450775). Extra riboflavin, thiamine.
* Alpha-Lipoic Acid (C-grade): Antioxidant. Review: (PMID: 26376825). 300-600mg daily.
* Creatine (C-grade): Energy buffer. Review: (PMID: 12679790). 5-10g daily.
* Vitamin E (C-grade): Membrane protection. Review: (PMID: 23075608). 400-800 IU daily.
* Folinic Acid (C-grade): CNS folate. Case series: (PMID: 27450775). 1-5mg daily.
Assessment targets: ECG, echocardiogram, ophthalmologic exam, audiogram, endocrine panel, neurological status, CK, lactate.
Protocol notes: Cardiac: heart block most serious complication; AV block can progress rapidly; prophylactic pacemaker often recommended even for asymptomatic conduction delays; sudden cardiac death reported. Eyes: ptosis surgery may help but can recur; strabismus surgery less successful. Hearing: aids if needed; cochlear implant sometimes. Endocrine: diabetes in ~15%; hypoparathyroidism (hypocalcemia); hypothyroidism; screen regularly. Nutrition: swallowing evaluation; may need thickened liquids, modified diet, or PEG. Anesthesia: propofol caution; avoid prolonged fasting; inform anesthesia team. Exercise: moderate activity OK when stable; avoid exhaustion. Fasting: avoid prolonged fasting; may need IV dextrose when ill. Genetic counseling: sporadic deletions (not inherited from mother unlike point mutations); very low recurrence risk. Idebenone: CoQ10 analog; studied in LHON, may help some. Research: gene therapy approaches under investigation.